Posted April 23, 2021
Bayer AG’s strategy to get a favorable ruling in its Roundup litigation is a manufactured “pay-to-appeal scheme” that will erode the U.S. system of justice if it’s permitted, plaintiffs’ lawyers said in a letter to a court. Lawyers who are helping lead the nationwide litigation over allegations that the weed killer causes cancer responded Thursday to a deal Bayer entered into that essentially pays a Georgia man to keep fighting the company in court. Read more.